The Impact of Radiolabeled Nanomaterials

Martha SahylíOrtega Pijeira; Natália Cristina Gomes da Silva; Luciana Magalhaes Rebelo Alencar; Eduardo Ricci-Junior; Ralph Santos-Oliveira

doi:10.2174/1874471016666230523155711

The Impact of Radiolabeled Nanomaterials

Curr Radiopharm. 2023;16(4):337-339. doi: 10.2174/1874471016666230523155711.

Authors

Martha SahylíOrtega Pijeira¹, Natália Cristina Gomes da Silva¹, Luciana Magalhaes Rebelo Alencar², Eduardo Ricci-Junior³, Ralph Santos-Oliveira^{1

4}

Affiliations

¹ Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de Janeiro, 21941906, RJ, Brazil.
² Department of Physics, Biophysics and Nanosystems Laboratory, Federal University of Maranhão, São Luis, 65065690, MA, Brazil.
³ School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, 21941900, RJ, Brazil.
⁴ Laboratory of Nanoradiopharmaceuticals, Rio de Janeiro State University, Rio de Janeiro, 23070200, RJ, Brazil.

PMID: 37226787
DOI: 10.2174/1874471016666230523155711

Abstract

Nanotechnology has changed the world, with a great impact on industry and medicine. In this commentary, we discuss the importance of radiolabeled nanomaterials for the construction of theranostic, imaging and therapeutic agents in order to pave the future of medicine.

Keywords: Nanotechnology; computed tomography; nano-radiopharmaceuticals; sentinel lymph; theranostic; therapeutic agents.

MeSH terms

Diagnostic Imaging
Nanostructures* / therapeutic use
Nanotechnology
Radiopharmaceuticals* / therapeutic use
Theranostic Nanomedicine

Substances

Radiopharmaceuticals